BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1084 related articles for article (PubMed ID: 28341421)

  • 21. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations.
    Rozhok AI; DeGregori J
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):8914-21. PubMed ID: 26195756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer development and progression: a non-adaptive process driven by genetic drift.
    Aranda-Anzaldo A
    Acta Biotheor; 2001; 49(2):89-108. PubMed ID: 11450810
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Colebatch AJ; Dobrovic A; Cooper WA
    J Clin Pathol; 2019 Apr; 72(4):281-284. PubMed ID: 30696697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-organ transcriptome variation across 21 cancer types.
    Hu W; Yang Y; Li X; Zheng S
    Oncotarget; 2017 Jan; 8(4):6809-6818. PubMed ID: 28036280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When Genome Maintenance Goes Badly Awry.
    Kass EM; Moynahan ME; Jasin M
    Mol Cell; 2016 Jun; 62(5):777-87. PubMed ID: 27259208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is cancer a disease set up by cellular stress responses?
    Aranda-Anzaldo A; Dent MAR
    Cell Stress Chaperones; 2021 Jul; 26(4):597-609. PubMed ID: 34031811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the earliest stages of colorectal tumorigenesis.
    Sievers CK; Grady WM; Halberg RB; Pickhardt PJ
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):723-729. PubMed ID: 28503955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative clonal selection in tumor evolution.
    Beckman RA; Loeb LA
    Genetics; 2005 Dec; 171(4):2123-31. PubMed ID: 16143627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.
    Huang S
    Prog Biophys Mol Biol; 2012 Sep; 110(1):69-86. PubMed ID: 22579660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of evolutionary processes in organismal and cancer evolution.
    Laukien FH
    Prog Biophys Mol Biol; 2021 Oct; 165():43-48. PubMed ID: 34509467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell Competition in Carcinogenesis.
    Madan E; Palma AM; Vudatha V; Trevino JG; Natarajan KN; Winn RA; Won KJ; Graham TA; Drapkin R; McDonald SAC; Fisher PB; Gogna R
    Cancer Res; 2022 Dec; 82(24):4487-4496. PubMed ID: 36214625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic alterations in hepatocellular carcinoma: An update.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoplastic growth: the consequence of evolutionary malignant resistance to chronic damage for survival of cells (review of a new theory of the origin of cancer).
    Monceviciƫte-Eringiene E
    Med Hypotheses; 2005; 65(3):595-604. PubMed ID: 15919162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why is cancer not more common? A changing microenvironment may help to explain why, and suggests strategies for anti-cancer therapy.
    Jiang X; Tomlinson IPM
    Open Biol; 2020 Apr; 10(4):190297. PubMed ID: 32289242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancer.
    Wang X; El-Halaby AA; Zhang H; Yang Q; Laughlin TS; Rothberg PG; Skinner K; Hicks DG
    Hum Pathol; 2017 Oct; 68():22-25. PubMed ID: 28438622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Damaging Effect of Passenger Mutations on Cancer Progression.
    McFarland CD; Yaglom JA; Wojtkowiak JW; Scott JG; Morse DL; Sherman MY; Mirny LA
    Cancer Res; 2017 Sep; 77(18):4763-4772. PubMed ID: 28536279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards a theory of evolutionary adaptation.
    Hartl DL; Taubes CH
    Genetica; 1998; 102-103(1-6):525-33. PubMed ID: 9720296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.